InstaPill Information

Here at InstaPill, we use our proprietary drug delivery technology to help our partners produce fast-acting, convenient medication for patients. Our rapid dissolve tablet technology is ideal for supporting lifecycle management projects, overcoming formulation challenges - specifically for products with low bioavailability - and meeting patient preferences for over-the-counter (OTC) medications. With capacity to produce 200 million rapid dissolve tablets annually from our state-of-the-art manufacturing facilities in India. InstaPill offers highly automated operations to improve speed, accuracy and quality, as well as ensuring dosage uniformity. Forming partnerships with our customers we offer flexible and agile solutions from development through to manufacture to get your products to market quickly and efficiently, reducing both cost and complexity. The InstaPill edge Increasing bioavailability • Pre-gastric absorption ideal for medications where bioavailability of the active ingredient is low. • Ability to tailor formulations to enable faster onset of therapeutic action. Improving patient convenience and compliance • Dissolve in less than 10 seconds. • No need to swallow, ideal for patients suffering from dysphagia i.e. geriatric and paediatric patient populations. • Convenient, on-the-go administration for improved patient compliance. • Taste masking, flavour enhancement and gelatin-free. Extending your product lifecycle • Support customers with lifecycle management programmes and potential exclusivities using regulatory strategies such as 505(b)(2). Making medication more accessible • Access to the expertise, in InstaPill and Tenshi Kaizen, to navigate complex formulation projects. • Specialist aseptic and lyophilisation capabilities for molecules with more challenging handling requirements. The possibilities are endless.